CDK2 INHIBITOR II
- Product Name
- CDK2 INHIBITOR II
- CAS No.
- 222035-13-4
- Chemical Name
- CDK2 INHIBITOR II
- Synonyms
- SC 221409;COMPOUND 3;CDK2 INHIBITOR II;CDK2-IN-3 (compound 3);SC 221409, Cdk2 inhibitor;4-(2-(5-Bromo-2-oxoindolin-3-ylidene)hydrazinyl)benzenesulfonamide;4-[2-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazinyl]-benzenesulfonamide;Benzenesulfonamide, 4-[2-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazinyl]-
- CBNumber
- CB7244623
- Molecular Formula
- C14H11BrN4O3S
- Formula Weight
- 395.23
- MOL File
- 222035-13-4.mol
CDK2 INHIBITOR II Property
- Melting point:
- >272°C (dec.)
- Density
- 1.85±0.1 g/cm3(Predicted)
- storage temp.
- Amber Vial, -20°C Freezer, Under inert atmosphere
- solubility
- DMSO (Slightly), Methanol (Slightly, Heated)
- form
- Solid
- pka
- 8.81±0.20(Predicted)
- color
- Light Orange to Orange
- InChI
- InChI=1S/C14H11BrN4O3S/c15-8-1-6-12-11(7-8)13(14(20)17-12)19-18-9-2-4-10(5-3-9)23(16,21)22/h1-7,18H,(H2,16,21,22)(H,17,19,20)
- InChIKey
- ODZNNZYRBRRREX-UHFFFAOYSA-N
- SMILES
- C1(S(N)(=O)=O)=CC=C(NN=C2C3=C(NC2=O)C=CC(Br)=C3)C=C1
N-Bromosuccinimide Price
- Product number
- 15154
- Product name
- Cdk2 Inhibitor II
- Purity
- ≥95%
- Packaging
- 500μg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 15154
- Product name
- Cdk2 Inhibitor II
- Purity
- ≥95%
- Packaging
- 1mg
- Price
- $57
- Updated
- 2024/03/01
- Product number
- 15154
- Product name
- Cdk2 Inhibitor II
- Purity
- ≥95%
- Packaging
- 5mg
- Price
- $166
- Updated
- 2024/03/01
- Product number
- C228120
- Product name
- CDK2inhibitorII
- Packaging
- 10mg
- Price
- $120
- Updated
- 2021/12/16
- Product number
- 6150CK
- Product name
- Cdk2InhibitorII
- Packaging
- 5mg
- Price
- $282
- Updated
- 2021/12/16
CDK2 INHIBITOR II Chemical Properties,Usage,Production
Description
The cyclin-
Uses
CDK2 inhibitor II, is a potent, cell-permeable, ATP-competitive, and selective inhibitor of Cdk2.
in vivo
CDK2-IN-3 (2.5-250 μg, topical application, once daily, for 1 week) significantly reduces the incidence of alopecia in neonatal rat model induced by the combination of cyclophosphamide (HY-17420) and doxorubicin (HY-15142A)[1].
| Animal Model: | Cyclophosphamide (HY-17420)-Doxorubicin (HY-15142A) combination chemotherapy-induced alopecia neonatal Sprague-Dawley rat model (13 days) |
| Dosage: | 2.5-250 μg |
| Administration: | Topical application, once daily for 1 week |
| Result: | Effectively prevented alopecia in 50% of rats and provided partial protection in an additional 20%. |
IC 50
CDK2: 60 nM (IC50)
References
[1] FUNK J. Cell Cycle Checkpoint Genes and Cancer[C]. 2006: 0. DOI: 10.1038/npg.els.0006046
[2] STEPHEN T. DAVIS, JR. Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors[J]. Science, 2001, 291 5501. DOI: 10.1126/science.291.5501.134
CDK2 INHIBITOR II Preparation Products And Raw materials
Raw materials
Preparation Products
CDK2 INHIBITOR II Suppliers
- Tel
- 18352410772
- seetech@126.com
- Country
- China
- ProdList
- 6
- Advantage
- 58
- Tel
- 18210857532; 18210857532
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 96815
- Advantage
- 76
- Tel
- 0330-2528181
- Fax
- 0330-2528171
- sales@vdmbio.com
- Country
- United States
- ProdList
- 510
- Advantage
- 64
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 021-58170097
- info@topbiochem.com
- Country
- China
- ProdList
- 9510
- Advantage
- 58
- Tel
- 021-33632979
- Fax
- 021-34692979
- info@tsbiochem.com
- Country
- China
- ProdList
- 8065
- Advantage
- 58
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9923
- Advantage
- 65
- Tel
- 13761635123
- Fax
- 1014988033@qq
- 1014988033@qq.com
- Country
- China
- ProdList
- 4941
- Advantage
- 55
- Tel
- 400-9205774
- sales@glpbio.cn
- Country
- China
- ProdList
- 6777
- Advantage
- 58
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
- Country
- China
- ProdList
- 57422
- Advantage
- 58